British Columbia is expanding treatment coverage for chronic hepatitis C to everyone in the province and has added a new drug to the province’s PharmaCare formulary. “In years past, a hepatitis C diagnosis was a stressful and lifelong struggle,” said Health Minister Adrian Dix, in a news release. “I’m pleased to share that, as of today, anyone […]
The new five-week parental sharing benefit announced in the 2018 federal budget is causing some concern among employers. Commenting on Benefits Canada’s website, Asha Mohammed, director of human resources and payroll at Centennial College’s Tribute Communities, asked: “Why a new leave again? This is such an expense to employers who are already stressed with all the leaves.” Dan Kelly, […]
British Columbia’s plan to eliminate or reduce prescription drug deductibles for low-income earners could also lead to lower drug costs for plan sponsors in the province. While Nick Gubbay, a principal and group benefits consultant at Eckler Ltd. in Vancouver, says the impact is likely to be most material for group plans providing benefits to […]
As the new year gets underway, it’s a busy season for predictions about what’s ahead for 2018. When it comes to employer-sponsored drug plans, costs have been a rising concern in recent years. According to projections released by Aon Hewitt in December, costs for extended health-care plans will likely rise by six per cent in […]
The pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association have reached a deal aimed at reducing the prices for some generic drugs by as much as 40 per cent. While the parties are touting significant savings for Canada’s public drug plans, they also say employers and patients will benefit from price reductions of 25 to 40 per cent, as of […]
Employers should review their drug plans annually to make sure they’re getting value for money, according to a speaker at the recent Face to Face Drug Plan Management forum. “It’s good drug plan management hygiene,” said Kim MacFarlane, assistant vice-president of group benefit product at Manulife Financial Corp. Even if the unwieldy nature of drug […]
What’s the impact of a potential national pharmacare program on private drug plans? Attendees heard the range of perspectives at the recent Face to Face Drug Plan Management Forum. The annual conference included a panel discussion about pharmacare, as well as sessions on hot topics in drug plans, such as drug price reform and pooling […]
From biosimilars to product listing agreements, a panel of experts tackled some of the hottest topics in drug plan management at the Face to Face Drug Plan Management forum on Dec. 14. Barbara Martinez, who heads up the national drug benefits solutions practice at the Great-West Life Assurance Co., addressed the question of biosimilars during […]
With 2017 coming to a close and 2018 on the horizon, professionals in the pension, investment, benefits and human resources industries have a number of dates to add to their calendars for the new year. Jan. 1: Ontario’s new youth pharmacare program takes effect. It will provide universal coverage of all medicines listed in the Ontario Drug Benefit […]
As Ontario prepares to roll out its new pharmacare program for youth on Jan. 1, plan sponsors and members will be watching to see how the transition to the public plan from private coverage will work. Of particular concern is the relationship between private plans and the exceptional access program, which facilitates access to drugs not listed on […]